Antidepressants encounter autophagy in neural cells

25Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

The prevailing view of antidepressants' (ADs) mode of action primarily focuses on their impact on neurotransmitter circuits, since the corresponding transporters and receptors are common targets of ADs. However, mounting evidence points to additional target structures, which may either support the beneficial effects or account for undesired side effects of ADs. Recently, we analyzed the influence of three ADs of different classes on autophagy-related processes in primary astrocytes and neurons. While amitriptyline (AMI) and citalopram (CIT) upregulate the expression of autophagic markers such as LC3B-II or Beclin 1, venlafaxine fails to exert these effects. Autophagy triggered by AMI and CIT is functional in terms of autophagic flux, and is partially mediated by class III PtdIns 3-kinase- and ROS dependent-pathways. Together, our study's results highlight a novel mode of action of ADs beyond monoaminergic neurotransmission. © 2011 Landes Bioscience.

Cite

CITATION STYLE

APA

Zschocke, J., & Rein, T. (2011). Antidepressants encounter autophagy in neural cells. Autophagy, 7(10), 1247–1248. https://doi.org/10.4161/auto.7.10.16520

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free